Noh B, Sung J, Kim Y, Chang S, Park Y. Prognostic value of ERG, PTEN, CRISP3 and SPINK1 in predicting biochemical recurrence in prostate cancer. Oncol Lett. 2016;11:3621-3630 pubmed

Yilmaz O, Berber U, Okcelik S, Soydan H, Ates F, Karademir K. TMPRSS2-ERG gene fusion in Turkish patients with localized prostate cancer: results of radical prostatectomy specimens. Turk J Urol. 2016;42:60-3 pubmed publisher

Winterhoff M, Brühmann S, Franke C, Breitsprecher D, Faix J. Visualization of Actin Assembly and Filament Turnover by In Vitro Multicolor TIRF Microscopy. Methods Mol Biol. 2016;1407:287-306 pubmed publisher

Haffner M, Weier C, Xu M, Vaghasia A, Gürel B, Gümüşkaya B, et al. Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization. J Pathol. 2016;238:31-41 pubmed publisher

Selvaraj N, Kedage V, Hollenhorst P. Comparison of MAPK specificity across the ETS transcription factor family identifies a high-affinity ERK interaction required for ERG function in prostate cells. Cell Commun Signal. 2015;13:12 pubmed publisher

Griner N, Young D, Chaudhary P, Mohamed A, Huang W, Chen Y, et al. ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer. Mol Cancer Res. 2015;13:368-79 pubmed publisher

Lotan T, Gumuskaya B, Rahimi H, Hicks J, Iwata T, Robinson B, et al. Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia. Mod Pathol. 2013;26:587-603 pubmed publisher